Provided by Tiger Fintech (Singapore) Pte. Ltd.

Intellia Therapeutics

7.25
-1.1900-14.10%
Post-market: 7.290.0400+0.55%18:00 EDT
Volume:4.19M
Turnover:31.60M
Market Cap:750.50M
PE:-1.38
High:8.24
Open:8.23
Low:7.24
Close:8.44
Loading ...

U.S. RESEARCH ROUNDUP- Constellation Brands, Merck, WD-40

Reuters
·
13 Jan

Intellia Therapeutics’ Strategic Reorganization and Promising Clinical Progress Justify Buy Rating

TIPRANKS
·
13 Jan

Intellia Therapeutics Inc : Jefferies Cuts Target Price to $86 From $128

THOMSON REUTERS
·
13 Jan

Intellia Therapeutics Inc : Oppenheimer Cuts Target Price to $40 From $60

THOMSON REUTERS
·
13 Jan

Strategic Focus and Financial Resilience: Terence Flynn’s Positive Outlook on Intellia Therapeutics

TIPRANKS
·
11 Jan

Analysts’ Top Healthcare Picks: Inozyme Pharma (INZY), Intellia Therapeutics (NTLA)

TIPRANKS
·
11 Jan

Intellia Therapeutics price target lowered to $60 from $70 at Wells Fargo

TipRanks
·
11 Jan

Intellia Therapeutics price target lowered to $50 from $70 at BMO Capital

TIPRANKS
·
10 Jan

NTLA Announces Strategic Reorganization & Job Cuts in 2025, Stock Down

Zacks
·
10 Jan

Wedbush Cuts Price Target on Intellia Therapeutics to $10 From $14, Keeps Neutral Rating

MT Newswires Live
·
10 Jan

Intellia Therapeutics Inc : Wedbush Cuts Target Price to $10 From $14

THOMSON REUTERS
·
10 Jan

BUZZ-Intellia declines on plans to stop development of lung disease therapy

Reuters
·
10 Jan

Intellia Therapeutics Inc : Leerink Partners Cuts Target Price to $39 From $55

THOMSON REUTERS
·
10 Jan

Strategic Realignment and Pipeline Potential Drive Buy Rating for Intellia Therapeutics

TIPRANKS
·
10 Jan

Intellia Therapeutics to Workforce by 27%, Halt Some Programs

MT Newswires Live
·
10 Jan

Intellia Therapeutics to Lay Off 27% of Workers in Reorganization

Dow Jones
·
10 Jan

Intellia Therapeutics announces net workforce reduction of 27% in 2025

TIPRANKS
·
10 Jan

Intellia Therapeutics announces retirement of CSO Laura Sepp-Lorenzino

TIPRANKS
·
10 Jan

Intellia Therapeutics: Phase 3 HAELO study to complete enrollment in 2H25

TIPRANKS
·
10 Jan

Intellia Therapeutics Inc -Anticipated Cost Savings, Including a Net Workforce Reduction of Approximately 27% in 2025

THOMSON REUTERS
·
10 Jan